快速订购： English
中文版
自主产品分类
快速订购： English
中文版
400-921-8278
| Catalog_no | BDAB0042 |
| Product_name | Recombinant SARS-CoV-2 (2019-nCoV) NSP1 protein |
| Category | 冠状病毒产品 |
| Applications | Immunogen |
| Size | 50ug/100ug/1mg |
| Price | 1800/2800/8800 |
| Specificity | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
| Formulation | Supplied as solution form in PBS, pH7.5 or lyophilized from PBS, pH7.5 |
| Source | E.coli |
| Storage_stability | Use a manual defrost freezer and avoid repeated freeze thaw cycles.Store at 2 to 8 °C for one week .Store at -20 to -80 °C for twelve months from the date of receipt. |
| othername | SARS-CoV 2 nsp1,SARS-CoV 2 Leader protein |
| Background | The Severe Acute Respiratory Syndrome (SARS) Coronavirus (CoV) is an enveloped, positive-stranded RNA viruses that can cause a severe respiratory disease. Its genome consists of a ～30 kb linear, non-segmented, capped, polycistronic, polyadenylated RNA molecule, the first two-third of which is directly translated into two large polyproteins. These two polypeptides are processed into 16 non-structural proteins (nsps), forming the replicase complex, which is active in the cytoplasm in close association with cellular membranes. Nsp1 was proved to be able to suppress host gene expression by promoting host mRNA degradation and was involved in cellular chemokine deregulation. This virus evades the host innate immune response in part through the expression of its non-structural protein (nsp) 1, which inhibits both host gene expression and virus- and interferon (IFN)-dependent signaling. Thus, nsp1 is a promising target for drugs, as inhibition of nsp1 would make SARS-CoV more susceptible to the host antiviral defenses. |
| Notes | NSP1 |
| description | Recombinant SARS-CoV-2 NSP1 is produced by E.coli expression system and the target gene encoding Met1-Gly180 is expressed with N-His Tag |
| Type | N-His |
| Purity | >90% as determined by SDS-PAGE |
| Molecular Weight | 21.94kDa |
| Instructions | 
查看与下载 |
| Share |
Copyright ? 2021 威尼斯城娱乐官方平台 版权所有 ，苏ICP备2021013855号-1 
